Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Advanced Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Status
- RECRUITING
- Phase
- PHASE3
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-B01D1 Combined With Lenvatinib in Patients With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
- Status
- SUSPENDED
- Phase
- PHASE1
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ligufalimab and Cadonilimab in Advanced Liver Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1